Q-omics provides the consensus-scored MTCYBP32 profile across patient tissues and cancer cell-line models. MTCYBP32 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in THCA. Additionally, MTCYBP32 RNA expression shows 11,349 significant protein co-abundance associations, with the highest sampling consensus in LSCC. Together, these results highlight THCA, and LSCC as cancer lineages where MTCYBP32 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.